Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial

Salvage radiotherapy (SRT) is utilized for biochemical progression of prostate cancer after radical prostatectomy (RP).To report the outcomes of the SAKK 09/10 trial comparing conventional and dose-intensified SRT.SAKK 09/10 was a randomized, multicenter, phase 3 trial that recruited men with biochemical progression after RP.Patients were randomly assigned to conventional-dose (64 Gy) or dose-intensified SRT (70 Gy) to the prostate bed without...